Fig. 7

Effects of nano-drug delivery systems on other tumor-associated cells. (A) Schematic illustration of preparation technology of Ce6&SB-3CT@MLRNs, dual-responsive drug release and mechanism of improving photodynamic immunotherapy for tumor (Adapted with permission from reference [133]) (B) Schematic illustration of ROS-activated cascade release of sorafenib synergistically enhances the antitumor effects of PDT. (C) CLSM images show the distribution of effector T cells, helper T, TAMs and MDSCs in tumor sections at the end of the tumor inhibition experiment (Adapted with permission from reference [138])